AbbVie is paying $200 million to snap up Nimble Therapeutics, a Roche spinout working to develop oral peptide treatments in the autoimmune space. As part of the acquisition, the North Chicago-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results